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1. Introduction 
Trypanosomatids are a monophyletic group of protozoa that diverged early from the 
eukaryotic lineage, constituting valuable model organisms for studying variability in 
different highly conserved processes including protein synthesis. Moreover, several species 
of trypanosomatids are causing agents of endemic diseases in the third world. There are 
many evidences suggesting that translation in these organisms shows important differences 
with that of model organisms such as yeast and mammals. These unique features, which 
have a great potential relevance for both basic and applied research, will be discussed in this 
chapter. 
2. Structural analysis 
2.1. Cryo-electron microscopy map of Trypanosoma cruzi ribosome:  
Unique features of the rRNA 
Using the cryo-electron microscopy (cryo-EM) technique, a 12Å resolution density map of 
the T. cruzi 80S ribosome has been constructed [1]. The overall structure of the T. cruzi 80S 
ribosome exhibits well defined small (40S) and large (60S) subunits (Figure 1). Some of the 
landmark characteristics of the ribosome structure can be identified in the density map. 
Compared with the 80S ribosome from yeast, both the small and large ribosomal subunits 
from T. cruzi are larger, mainly due to the size of the ribosomal RNA molecules. T. cruzi 
rRNA (18S rRNA: 2,315 nt and 28S rRNA: 4,151 nt) is one-fifth larger than yeast rRNA (18S 
rRNA: 1,798 nt; 25S rRNA: 3,392 nt) in total number of nucleotides. 
Although the T. cruzi 80S ribosome possesses conserved ribosomal structures, it exhibits 
many distinctive structural features in both the small and large subunits. Compared with 
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other eukaryotic ribosomes, the T. cruzi ribosomal 40S subunit appears expanded, due to the 
addition of a large piece of density adjacent to the platform region (Figure 1). As can be seen 
in the secondary structure of the T. cruzi 18S rRNA (Figure 2), this extra density must be 
attributed to two large expansion segments (ES) in domain II of the 18S rRNA, ES6 and ES7, 
designated as insertions of helices 21 and 26. These are the two largest ES in the T. cruzi 18S 
rRNA, involving 504 and 147 nucleotides, respectively. 
 
Figure 1. Cryo-electron microscopy map of T. cruzi 80S ribosome. Blue: large subunit. Yellow: small 
subunit. Landmark characteristics are indicated: SB, stalk base; SRL, sarcin-ricin loop; L1, L1 protein; 
CP, central protuberance; pr, prong. 
Part of ES6/ES7 makes up a large helical structure (named the ‘‘turret’’), located at the most 
lateral side of the 40S subunit (Figures 1 and 2). The turret measures 205 Å in length and 
forms the longest helical structure ever observed in a ribosome. The upper end of the turret 
appears as a sharp, freestanding spiral of 50 Å in length, named ‘‘spire,’’ located next to the 
exit of the mRNA channel. The distance between the spire and the mRNA exit is ~130 Å. The 
lower portion of the turret extends all of the way to the bottom of the 40S subunit. At its 
lower end, it bends by almost 90° and forms a bridge with the 60S subunit. This is a unique 
type of connection between the small and large subunits, as compared with all other ribosomal 
structures investigated to date [2]. Apart from the turret, the extra density in the 40S subunit 
also includes several small helical structures as part of ES6 and ES7. These helical structures 
observed in the density map are in accordance with the comparative analysis result based on 
ES6 sequences from >3,000 eukaryotes, in which several helices were identified only in 
kinetoplastida [3]. The ES3, ES9, and ES10 are located near helices 9, 39, and 41, respectively, 
and are associated with three small masses in the density map of the 40S ribosomal subunit, 
one at the bottom of the 40S ribosomal subunit, the other two in the head region. 
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Figure 2. Secondary structure of T. cruzi 18S rRNA with the characteristic ES. The 40S subunit was 
superposed with the crystallized S. cerevisiae 18S rRNA (PDB: 3U5E). The volume occupied by ES6 and 
ES7 is indicated. 
In contrast to the other rRNA regions, ES12, located in the long penultimate helix from 18S 
rRNA, is shorter in T. cruzi compared to other eukaryotes. This results in the helix 44 in T. cruzi 
(113 nt) being longer than in E. coli (103 nt), but shorter than in yeast (129 nt). Consistently with 
these variations in length, the span of the density attributable to helix 44 in the T. cruzi ribosome 
also has an intermediate position between E. coli and yeast. Interestingly, this region forms the 
decoding center, and is also the action site of aminoglycoside antibiotics. Moreover, differences 
in this region have shown to be responsible for the higher susceptibility of trypanosomatid 
ribosomes to the aminoglycoside paromomycin [4], as will be discussed below. 
The T. cruzi 60S subunit contains several large extra densities located at its periphery, in 
contrast with the large ribosomal subunit in yeast. The most common structures can be 
identified, such as the central protuberance (CP), L1 stalk, and stalk base of P proteins, as 
well as the conserved rRNA core structure (Figure 1). Although the secondary structure of 
the T. cruzi rRNAs in the 60S subunit is not available, the locations of most of the observed 
extra densities are consistent with the general locations of the rRNA expansion segments, 
which are, as a rule, at the surface of eukaryotic ribosomes. Among the extra densities, there 
is a large helical structure (‘‘prong’’) located between the CP and helix 38, in the back of the 
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60S subunit (Figure 1, pr). Interestingly, a similar feature was reported only in the structure 
of the human ribosome, but not in yeast neither bacterial ribosomes [5]. Morphological 
comparison of the 60S ribosomal subunit from T. cruzi with those from yeast and higher 
eukaryotes reveals that the T. cruzi 60S ribosomal subunit does not possess the universal 
eukaryotic feature of a planar surface near the exit site of polypeptide [2]. Instead, the 60S 
ribosomal subunit from T. cruzi presents a shape that is similar to those from bacteria. In 
contrast to the conserved eukaryotic rRNA core structure, the location of the L1 stalk in T. 
cruzi, which is on one side of the CP, does not match either of the two reported positions in 
yeast, known as the ‘‘in position’’ and ‘‘out position,’’ in relation to the ratchet-like subunit 
rearrangement. Instead, the L1 stalk in T. cruzi takes an in-between position, possibly due to 
its high mobility. On the other side of the CP, the P protein stalk is not visible in the density 
map of the T. cruzi 60S ribosomal subunit, whereas Western blots of the ribosome 
preparation using monoclonal antibodies against P proteins (P0/P1/P2) showed that these 
proteins were present in the ribosome preparation. As homologs of the bacterial moiety 
L10/(L7/L12)4, P proteins are known to be very flexible, and the absence of a stalk in the 
cryo-EM density map is likely due to the lack of stabilization. A complete description of T. 
cruzi stalk region, components, interactions and complex formation will be discussed below. 
2.2. Sequence and proteomic analysis: Differences on the ribosomal proteins 
The Cryo EM map of T. cruzi ribosomes exposed important differences in comparison with 
the corresponding organelles of model organisms such as S. cerevisiae and mammals [1]. 
Some of them were attributed to large expansions in the primary sequence of the ribosomal 
RNA molecules. However, the presence of specific features due to ribosomal proteins is 
difficult to demonstrate by this technique. Therefore, using the S. cerevisiae ribosomal 
protein sequences as probes, it was possible to identify in the T. cruzi genome database all 
homologue genes [6]. The average amino acid identity between the S. cerevisiae and T. cruzi 
ribosomal proteins was remarkably low (~50%), taking into account the high degree of 
conservation of the ribosome through evolution.  
The ribosomal proteins inferred by data mining were compared to the MS analysis results 
from whole parasites [7] and purified ribosomes [6]. Results are summarized in Tables 1 and 
2 for proteins from the large and small subunits, respectively.  
 
S. cerevisiae T. cruzi 
Prot 3U5E Length (aa) Length (aa) % ID Prot MS Ribo MS 
L1 - 217 214 51 + - 
L2 + 254 260 62 + + 
L3 + 387 428 57 + + 
L4 + 362 374 49 + + 
L5 + 297 309 49 + + 
L6 + 176 193 43 + + 
L7 + 244 242 41 + + 
L8 + 256 315 47 + + 
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S. cerevisiae T. cruzi 
Prot 3U5E Length (aa) Length (aa) % ID Prot MS Ribo MS 
L9 + 191 189 46 + + 
L10 + 221 213 61 + + 
L11 + 174 192 69 + + 
L12 - 165 164 56 + + 
L13 + 199 218 39 + + 
L14 + 138 180 30 + + 
L15 + 204 204 57 + + 
L16 + 199 222 44 + + 
L17 + 184 166 54 + + 
L18 + 186 193 43 + + 
L19 + 189 357 50 + + 
L20 + 174 179 37 + + 
L21 + 160 159 41 + + 
L22 + 121 130 33 - + 
L23 + 137 139 69 + + 
L24 + 155 125 32 + + 
L25 + 142 226 45 + + 
L26 + 127 143 57 + + 
L27 + 136 133 43 + + 
L28 + 149 145 59 + + 
L29 + 59 71 82 + + 
L30 + 105 105 55 + + 
L31 + 113 188 42 + + 
L32 + 130 133 42 + + 
L33 + 107 149 42 + + 
L34 + 121 170 38 + + 
L35 + 120 127 44 + - 
L36 + 100 114 41 + + 
L37 + 88 84 57 + + 
L38 + 78 82 43 - + 
L39 + 51 51 60 - - 
L40 + 52 52 65.4 + - 
L41 + 25 Not Found
L42 + 106 106 65 - + 
L43 + 92 90 61 + + 
Table 1. Proteins from the large subunit. Left, S. cerevisiae: protein name, presence in the crystal 
structure (PDB: 3U5E) and number of residues. Right, T. cruzi homologues: amino acid length, 
percentage of identity and positive (+) or negative (-) detection by MS on whole parasites (Prot MS) or 
purified ribosomes (Ribo MS). 
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S. cerevisiae T. cruzi 
Prot 3U5C Length (aa) Length (aa) % ID Prot MS Ribo MS 
S0 + 252 245 52 + + 
S1 + 255 261 40 + + 
S2 + 254 263 58 + + 
S3 + 240 214 58 + + 
S4 + 261 273 50 + + 
S5 + 225 190 64 + + 
S6 + 236 250 49 + + 
S7 + 190 211 34 + + 
S8 + 200 221 47 + + 
S9 + 197 190 59 + + 
S10 + 105 161 34 + + 
S11 + 156 173 54 + + 
S12 + 143 
142 30.8 + + 
141 34.5 + - 
S13 + 151 151 62 - + 
S14 + 137 144 74 + + 
S15 + 142 152 53 + + 
S16 + 143 149 56 + + 
S17 + 136 141 57 + + 
S18 + 146 153 58 + + 
S19 + 144 167 35 + + 
S20 + 121 117 41 + + 
S21 + 87 251 43 + + 
S22 + 130 130 72 + - 
S23 + 145 143 68 + + 
S24 + 135 137 47 + + 
S25 + 108 110 39 + - 
S26 + 119 112 42 + + 
S27 + 82 86 61 + + 
S28 + 67 91 68 - + 
S29 + 56 57 54 + + 
S30 + 63 65 65 - - 
S31 + 152 150 60 + + 
RACK1 + 319 317 43 + + 
Table 2. Proteins from the small subunit. Left, S. cerevisiae: protein name, presence in the crystal 
structure (PDB: 3U5C) and number of residues. Right, T. cruzi homologues: amino acid length, 
percentage of identity and positive (+) or negative (-) detection by MS on whole parasites (Prot MS) or 
purified ribosomes (Ribo MS). 
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This analysis showed that T. cruzi ribosomal proteins are, in average, longer than the 
corresponding S. cerevisiae proteins. The extra regions in T. cruzi ribosomal proteins are 
generally at the N- or C-terminal ends. The most intriguing examples of these terminal 
extensions, when comparing to yeast, are TcL19 and TcS21 (blue rows on Tables 1 and 2, 
respectively), showing C-terminal extensions of 168 and 164 amino acids, respectively. 
These extensions are only present in kinetoplastids, although their length varies among 
species. MS analyses of T. cruzi ribosomes confirmed the presence of peptides matching to 
TcL19 and TcS21, strongly suggesting that these genes correspond to the functional 
ribosomal components [6]. The possible functional roles of these extensions, as well as the 
molecular mechanisms that generated them over time, constitute interesting fields for future 
studies. 
It is interesting to note that S. cerevisiae L19 protein has been described as forming part of the 
polypeptide chain exit channel [8]. In addition to L19, the polypeptide chain exit channel is 
formed by L17, L25, L26, L31 and L35. All of these proteins show important extensions in T. 
cruzi, ranging from 41 amino acids (L35) up to 57 amino acids (L26). This fact can be related 
to the absence of a flat surface on this region in T. cruzi 80S ribosome, in contrast to the 
corresponding region in the yeast ribosome [1]. 
Two putative homologue genes for the S12 protein sharing 65% of amino acids identity are 
present in the T. cruzi genome (named TcS12A and TcS12B). TcS12A is slightly closer to 
yeast S12 (34.5% of amino acids identity) than TcS12B (30.8% of amino acids identity). Both 
genes were expressed at the protein level [7] but only TcS12B was detected in the proteomic 
analysis of purified ribosomes (Table 2). Interestingly, there are also two genes in T. brucei 
(S12A and S12B) but only one in L. major, suggesting a gene duplication event after the 
divergence of Leishmania spp into the trypanosomatid lineage. 
In other eukaryotes, such as mammals and yeast, ribosomal proteins S31 and L40 are 
synthesized as a C-terminal fusion with ubiquitin. Data mining revealed similar fusion 
genes in the T. cruzi genome. From these ubiquitin fusion proteins, only TcS31 (also named 
S27A) was detected by mass spectrometry on pure ribosomes. 
Out of the 32 proteins found by sequence identity to S. cerevisiae 40S proteins, 29 were 
detected by MS of T. cruzi ribosomes, including S13 and S28, which had not been detected in 
the proteome of T. cruzi [7]. Nevertheless, peptides matching to S22, S25 and S30 were not 
detected in the MS analysis of pure ribosomes. Interestingly, S30 was also not detected in 
MS studies on total extracts of T. cruzi (red row Table 2) [7]. 
For the large subunit (60S), out of the 48 yeast proteins screened, 47 were found to have a 
homologous gene in T. cruzi. The exception was L41, a short peptide of 25 amino acids long. 
The ribosome MS analysis detected all predicted proteins, excepting L1, L35, L39 and L40. 
From these, L1 and L35 were previously detected in epimastigote crude extracts [7]. 
Moreover, ribosome MS analysis detected two large subunit proteins that were not 
previously detected in the T. cruzi total proteome; L22 and L42 (Table 1). 
 
Cell-Free Protein Synthesis 10 
In addition to the previously discussed large and small subunit proteins (S and L), MS 
analyses detected other well-known ribosome components. Here we discuss some examples: 
i. RACK1, a protein tightly associated to the small ribosomal subunit in eukaryotes, and 
apparently involved in the regulation of translation initiation [9, 10]. This protein, 
present on the cryo-EM map of yeast ribosome was not detected on the cryo-EM map of 
T. cruzi (Figure 3). This difference can be explained by a weaker interaction between 
RACK1 and the ribosome in T. cruzi, compared to other species. This could result in too 
low amounts of RACK1 in purified ribosomes for cryo-EM visualization, but sufficient 
for MS detection. 
ii. The ribosomal P proteins, a pentameric complex that form a long and protruding stalk 
on the large subunit involved in the translocation of the ribosome during the elongation 
step of protein synthesis. This complex is generally absent in cryo-EM and has not yet 
completely elucidated by crystallography due to its high flexibility (Figure 3). All 
proteins that form the P complex in T. cruzi were detected in purified ribosome 
particles, indicating the presence of a functional pentameric complex. A complete 
description of T. cruzi stalk region, components, interactions and complex formation 
will be discussed below. 
 
Figure 3. Left, Cryo-EM of the T. cruzi 80S ribosome. Center, superposition of T. cruzi and S. cerevisiae 
80S particles. Right, Cryo-EM of the S. cereviseae 80S ribosome. Rack1 and the stalk region, which are 
only present in S.cerevisiae ribosome are indicated. 
2.3. The ribosomal stalk: variable components and assembly 
The large subunit of the eukaryotic ribosome possesses a long and protruding stalk formed 
by the ribosomal P proteins. This structure is involved in the translocation of the ribosome 
during the elongation step of protein synthesis through interaction with the elongation 
factor 2 (EF-2) [11]. Although the elongation step is a highly conserved process, the stalk is 
one of the most variable regions of the ribosome. The proteins forming this structure in 
prokaryotes and eukaryotes show very low sequence similarity. Moreover, among 
eukaryotes, the composition of the stalk is also variable, due to gene duplications and 
sequence divergence of genes encoding P proteins. In general terms the eukaryote complex 
is formed by the ribosomal P proteins, including P0 (a 34 kDa polypeptide) as a central 
component of the stalk and two distinct but closely related proteins of about 11 kDa, P1 and 
P2. The number of ribosomal P1/P2 proteins varies among species and these variations have 
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consequences in the stalk composition. In mammals, the P1 and P2 families have only one 
member and the stalk is formed by two identical copies of each P1 and P2 proteins, linked to 
P0 [12]. The binding of P2 protein to P0 can only be detected in the presence of P1, 
suggesting a pivotal role of the latter in the conformation of the stalk [13]. In S. cerevisiae 
there are two P1 (α and β) and two P2 (α and β) proteins [14] and the stalk seems to be 
organized in preferential pairs; P1α/P2β and P1β/P2α. Again, both P1 proteins seem to be 
necessary for the binding of the corresponding P2 partners to P0 [15]. In T. cruzi, five 
components of the stalk have been identified: P0, of approximately 34 kDa, containing a C-
terminal end that deviates from the eukaryotic P consensus and bears similarity with 
Archaea L10 protein; and four proteins of about 11 kDa (P1α, P1β, P2α and P2β) with the 
typical eukaryotic P consensus sequence at their C-terminal end [16, 17]. It should be noted 
that independent gene duplication events have originated the P1 and P2 subtypes in yeast 
and trypanosomatids.  
Combining yeast two-hybrid technique and surface plasmon resonance (SPR) it was possible 
to make a complete interaction map of T. cruzi ribosomal P proteins [17-19]. These two 
techniques were both necessary to fully characterize the complex and to map the interaction 
regions in P0 (Figure 5). This analysis exposed some trypanosomatid-specific features 
among P proteins interactions. TcP0 protein (the central component of the stalk) was able to 
interact with all P1/P2 proteins. Both P1 proteins were unable to interact with each other nor 
to homo-oligomerize. Interestingly, both P2 proteins showed a highly redundant interaction 
profile but P2α was not able to interact with P1α. Therefore, if we focus in a T. cruzi stalk 
composed of five different ribosomal P proteins the only possible arrangement for the low 
molecular weight protein association will be: P1α-P2β/P1β-P2α. Any other possible 
combination will exclude one of the four components. This association pattern resembles 
that observed in yeast; although not completely, because of the presence of highly 
interacting components like P2β. Consequently, it is possible to postulate heterogeneity on 
the stalk composition in T. cruzi, due to redundancy of some of its components. 
 
Figure 4. Surface image of yeast 80S ribosome crystallography in complex with the EF- 2 (red). The 
postulated location of the ribosomal P proteins on the stalk region of the large subunit is illustrated. 
Since all four small P proteins can bind to P0 the question was whether TcP0 can 
simultaneously bind two or four proteins. Despite the accumulated data about stalk 
organization in several model organisms, the interaction among P0 and P1/P2 proteins is not 
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completely understood at the molecular level. Tsurugi and Mitsui [20], based on sequence 
analysis of S. cerevisiae and H. sapiens P0, proposed the presence of eight putative hydrophobic 
zippers involved in the interaction with P1 and P2 proteins. Functional complementation 
assays in yeast using C-terminal truncated P0 variants showed that deletion of 87 amino acids 
(the entire putative hydrophobic zipper) abolishes the binding of P1/P2 proteins to the 
ribosome [21]. Using yeast two-hybrid technique (Y2H), it has been shown that the 100 amino 
acid long C-terminal domain of P0 strongly interacts with P1 and P2 proteins [22]. However, 
the last 50 amino acids of P0 (including only two of the eight hydrophobic residues) were not 
able to interact with P1/P2. More recently, using Y2H and deletion mutant strains, the P0 
region between positions 213 and 260 has been involved in the interaction with the P1/P2 
proteins in S. cerevisiae. In contrast, mutation of the putative interacting leucine residues in this 
region did not impair the binding of P1 and P2 proteins [23]. Based on the crystal structure of 
the archaeon Pyrococcus horikoshii stalk complex recently reported [24], it was possible to 
identify two putative P1/P2 interaction sites in TcP0. The first site is situated between 
aminoacids 222 and 232 and the second between aminoacids 248 and 258. Although the 
general mechanism mediating the interaction between P0 and P1/P2 proteins seems to be 
similar among all species, it should be noted that some of the residues on TcP0 involved in this 
interaction are not strictly conserved. This result is in agreement with other studies showing 
that ribosome from yeast strains carrying heterologous P0 proteins are not able to bind S. 
cerevisiae P1/P2 proteins efficiently [25, 26]. Altogether our data indicate that TcP0 possesses 
two P1/P2 interaction sites and that P1/P2 proteins can associate in pairs (P1α-P2β/P1β-P2α) 
but it was not known whether a hierarchy for P1/P2 association to TcP0 exists. To answer this 
question we performed a sequential SPR analysis in which we randomly injected one protein 
after the other (P1/P2) without regeneration steps on a sensor chip containing TcP0 [19]. This 
study showed that it is possible to form stable pentameric complexes when any of both P1 
proteins were first injected. There were a few other combinations that raised stable complexes 
but in general terms it is possible to conclude that the injection of multi-interacting proteins 
(like P2β and to a lesser extent P2α) at the beginning blocks the binding of the other 
components of the complex. This also means that other complexes containing not all P1/P2 
proteins are possible. Unfortunately, there are no functional data available. 
 
Figure 5. Summary of P protein interactions assessed by SPR and yeast two hybrid technique (Y2H). 
NA: Not analyzed. 
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Finally, the complete picture of the system can be illustrated in Figure 6, where the T. cruzi 
stalk resembles that of yeast due to the ability of all P1/P2 proteins to interact with P0. 
 
Figure 6. Assembly of the P complex in mammals, yeast and the proposed model for T.cruzi complex. 
As it was mentioned before, the C-terminal end of ribosomal P proteins interacts with EF-2 
and this interaction is essential during the elongation step of protein synthesis. Notably, 
antibodies against the C-terminal end of T. cruzi ribosomal P proteins are present in the sera 
of a high percentage of chronic chagasic patients. These antibodies are specific for the T. 
cruzi C-terminal peptide of ribosomal P proteins, being unable to recognize the mammalian 
epitope. This specificity is due to only one amino acid change (Ser by Glu) [27-30]. In a 
previous work, we have obtained a recombinant single chain antibody (scFvC5), derived 
from a monoclonal antibody against the C-terminal region of T. cruzi P2β protein [31, 32]. 
This recombinant antibody, similarly to human antibodies from chagasic patients, shows 
very high selectivity toward the parasite epitope. In Western blot assays, scFvC5 specifically 
recognized P proteins on extracts of trypanosomatids T. cruzi. T. brucei and Crithidia 
fascilculata, but it did not detect their rat counterparts. Based on earlier reports showing that 
antibodies (and their recombinant single chain versions) directed against the mammalian C-
terminal end of P proteins inhibit protein synthesis in cell-free systems [33], we reasoned 
that scFvC5 would selectively block translation process by trypanosomatid ribosomes. As 
expected, scFvC5 strongly inhibited the incorporation of radioactive amino acids when 
trypanosomatid ribosomes (from T. cruzi, T. brucei and C. fasciculata), but not mammalian 
(Rattus norvegicus) ribosomes were used under identical experimental conditions [30]. 
Moreover, the translation inhibition on trypanosomatid ribosomes could be reverted by pre-
incubation of the scFvC5 with the peptide corresponding to the T. cruzi epitope, but not with 
the mammalian equivalent. Therefore, we evaluated the ability of this recombinant antibody 
to inhibit protein synthesis in vivo, by using a tightly regulated inducible expression vector 
in T. brucei. The growth of parasites was significantly delayed when the scFvC5 expression 
was induced; clearly showing that blocking of the C-terminal end can be used as a strategy 
to inhibit trypanosomatid protein synthesis in vivo. In addition, and taking into account that 
the crystal structure of the monoclonal antibody originating scFvC5 has been reported [34] 
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(PDB 3SGE), the antibody combining site would be an interesting starting point for 
designing peptide mimetics as specific inhibitors of trypanosomatid translation. 
3. Functional analysis 
3.1. Translation activity: Initiation and elongation factors 
3.1.1. Trans-splicing of trypanosomatid mRNAs 
In several organisms, a variable proportion of mRNAs are processed by a mechanism 
named spliced-leader (SL) trans-splicing, which transfers a short RNA sequence (the SL) 
from the 5´ end of a specialized non-mRNA molecule, the SL RNA, to unpaired splice-
acceptor sites on pre-mRNA molecules. As a result, depending on the organism, a variable 
proportion of the mRNAs acquires a common 5´ sequence. The SL trans-splicing mechanism 
is widely and patchily distributed across phylogenetically distant organisms. The 
evolutionary origin of this process is still an enigma, and two different hypotheses have 
been postulated [35]: 
i. SL trans-splicing was present in an ancestral eukaryotic organism and has been lost in 
many different lineages, or 
ii. SL trans-splicing appeared independently several times during evolution of eukaryotes. 
Although this point has not been solved yet, recent evidences from analysis of large ESTs 
and genomic databases, seem to better support the second hypothesis [36, 37]. 
Several different functions for the SL sequences have been reported [35], among them: 
i. providing a 5´ cap structure for protein coding RNAs transcribed by RNA polymerase I 
ii. Converting polycistronic transcripts into capped, monocistronic mRNAs 
iii. enhancing mRNA translational efficiency 
In trypanosomatids, 100 % of their mRNA is processed by SL trans-splicing, adding a 39 nt 
sequence. Besides the universally conserved 7-methyl guanosine cap, which is linked to the 
first nucleotide via a 5´-5´ triphosphate bridge, the first four nucleotides of the SL are all 
methylated at the ribose ring. In addition, the first (m26A) and fourth (m3U) nucleotides are 
methylated at the base [38] (Figure 7). This unusually modified structure, known as the cap-
4, is the most highly modified cap structure of all eukaryotic cells. Due to the important role 
of the mRNA 5´ end during eukaryotic translation initiation, a role for the SL structure has 
been proposed in the process. By using cell lines of Leishmania tarentolae expressing modified 
SL sequences, it has been shown that these modifications do not affect transcription nor 
trans-splicing efficiency. In contrast, mutations of the SL region spanning nucleotides 10-29 
decreased the methylation extent and polysome association of mRNAs, demonstrating a 
direct role for the cap4 methylations and/or the primary sequence of the SL in the translation 
process [39]. More recently, Zamudio et al used Trypanosoma brucei strains lacking one or 
more of the three 2´-O-ribose methyl transferases involved in the cap4 biogenesis, to 
specifically evaluate the role of SL methylation in the absence of sequence changes [40]. In 
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this study, attempts to derive cells with complete loss of mRNA cap ribose methylation 
were unsuccessful, indicating an essential role in kinetoplastid biology. Moreover, even 
when cells lacking the kinetoplastid-specific ribose methylation at positions 3 and 4 were 
viable, they showed a decreased rate of protein synthesis, clearly showing a role for these 
modification (in the absence of SL sequence changes) in the translation process. The above 
mentioned evidences, demonstrating a direct role of hypermethylated SL in trypanosomatid 
protein synthesis, reinforce the hypothesis that translation initiation would show unique 
features in these organisms. 
 
Figure 7. The T. cruzi spliced leader sequence 
3.1.2. Initiation factors 
Cap-dependent initiation in eukaryotes is a very complex, highly regulated limiting step of 
translation. In this process, the 5´ cap interacts with a multi-protein complex named eIF4F, 
formed by at least three proteins: eIF4A, an ATP-dependent RNA helicase; eIF4E, the cap-
binding protein; and eIF4G, a scaffold protein that interacts with the poly(A) binding protein, 
IF4A and IF4E. Data mining on the Leishmania major genome database has revealed four 
eIF4Es (LmEIF4E1-4), two eIF4As (LmEIF4A1-2) and five eIF4Gs (LmEIF4G1-5) putative 
proteins [41]. 
The presence of multiple homologues for the different IF4F subunits in trypanosomatids, and 
in some cases in other eukaryotes, makes it difficult to identify these proteins that are actually 
involved in translation. In addition, knowledge of the protein synthesis in trypanosomatids is 
inferred by indirect evidences such as sequence similarities. Moreover, proteins with high 
homology to translation initiation factors are involved in other processes such as mRNA 
processing. Since orthologous proteins have, in general, conserved functional roles, 
phylogeny analysis could have some clues for identifying those proteins involved in protein 
synthesis. Below we discuss the biochemical, molecular and phylogenetic evidences available 
on the IF4F components. 
3.1.3. Trypanosomatid eIF4E 
A recent phylogenetic analysis of IF4E-family members has revealed that many organisms 
contain multiple genes encoding proteins with sequence similarity to prototypical IF4E 
proteins [42]. Unfortunately, no trypanosomatid IF4E-family members were included in this 
analysis. 
The highly modified cap of trypanosomatids suggests that eIF4E orthologous in these 
organisms would show atypical features. The L. major genome revealed four putative eIF4E 
encoding genes (named LeishIF4E-1 to -4) with limited homology. All of them have easily 
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identifiable orthologues in T. brucei and T. cruzi, suggesting that their functional roles are 
conserved among trypanosomatids, as can be inferred from phylogenetic analysis (Figure 8). 
In contrast, the phylogenetic relationships between putative trypanosomadid IF4E proteins 
and the homologous translation factors characterized in other species seem to be much more 
complex. This complex evolutionary scenario strongly suggests that multiple gene 
duplications have taken place during evolution of IF4E homologous genes, some of them 
before, and others after the evolutionary divergence between organisms, yielding both 
paralogous and orthologous genes. In spite of this complexity, it is clear that trypanosomatid 
IF4E-2 and IF4E-3 are paralogous genes originated by duplications into the trypanosomatid 
lineage. 
The L. major genes have been cloned and their respective protein products have been 
biochemically characterized [43]. The corresponding recombinant proteins showed variable 
relative affinities for chemically synthesized mammalian and trypanosomatid cap structures. 
Despite a detailed study of these proteins, including pull-down assays with a mammalian 
interacting partner of eIF4E, analysis of co-sedimentation with polysome fractions and 
detection at different stages of the parasite, no clear conclusions could be obtained leading to 
an eIF4E candidate. Moreover, none of these proteins was able to rescue the phenotype of a S. 
cerevisiae null strain, indicating a significant functional divergence of these proteins in the 
trypanosomatid lineage. This conclusion is reinforced by the observation that several eIF4E 
homologues from phylogenetically distant organisms (mammals, Drosophila melanogaster, 
zebrafish and Arabidopsis) are functional in yeast (red letters in Figure 8) [44-47]. Interestingly, 
other IF4E homologous from these species are not functional in yeast, suggesting that they 
are involved in roles other than translation initiation (i.e. translation repression, binding to 
nuclear mRNAs). 
More recently, the orthologue genes from T. brucei (TbEIF4E-1 through 4) have been 
functionally analyzed in vivo [50]. By using RNAi knock down of different TbIF4E genes, 
combined with metabolic labeling with radioactive amino acids, this study strongly 
suggested that TbIF4E-3 (and also probably TbIF4E-4) are directly involved in protein 
synthesis. This is supported by their cytosolic localization, in contrast to the TbIF4E-1 and 2 
proteins, which are both nuclear and cytosolic. Unfortunately, no yeast complementation 
assays were performed with T. brucei proteins which could be correlated with the data of 
their L. major orthologues. 
A similar situation seems to take place in the ancient eukaryotic, non-kinetoplastid, Giardia 
lamblia. Two IF4E homologous proteins have been identified and characterized; Gl_IF4E-1 
and Gl_IF4E-2. Notably, Gl_IF4E-1 seems to be the orthologous gene of LmIF4E-4, whereas 
Gl_IF4E-2 is more closely related to LmIF4E-1. This suggests that duplications of genes 
encoding IF4E-family proteins have taken place very early during eukaryotic evolution. 
Functional analyses suggest that Gl_IF4E-2 is involved in protein synthesis. However, 
similarly to the Leishmania proteins, none of these IF4E homologues is able to rescue a null 
phenotype in yeast [51]. These observations suggest that early eukaryotes, such as Giardia 
and trypanosomatids, have major functional differences with model organisms in protein 
synthesis initiation, particularly in the case of IF4E. Moreover, it seems that after divergence  
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Figure 8. Inferred phylogenetic relationships among putative trypanosomatid IF4E proteins and 
homologous proteins from other eukaryotes. Sequences are derived from H. sapiens (Hs), Mus musculus 
(Mm), S. cerevisiae (Sc), Drosophila melanogaster (Dm), Giardia lamblia, (Gl), Arabidopsis thaliana (At), Danio 
rerio (zebra fish) (Dr), L. major (Lm), T. brucei (Tb) and T. cruzi (Tc). Accession codes for GenBank or L. 
major database (http://www.genedb.org/Homepage/Lmajor) are shown in parenthesis. Sequences 
covering the IF4E domain (PFAM 01652) were aligned using T-COFEE under default parameters 
(http://tcoffee.vital-it.ch). LG+G was chosen as the best evolutionary model using ProtTest [48]. PhyML 
was run using the algorithm Subtree Pruning and Regrafting (SPR) [49] with 5 initial starting trees. To 
estimate the robustness of the phylogenetic inference, 500 bootstrap replicates were run. Color letters 
indicate whether these proteins are able (red) or unable (green) to complement a S. cerevisiae deficient 
strain. Arrows indicate the proteins that have proved functional roles in protein synthesis in ancient 
eukaryotes (trypanosomatid and Giardia). 
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of Giardia and trypanosomatid lineages, different paralogous genes acquired a major 
functional role in protein synthesis initiation, giving an additional level of complexity to the 
evolution of IF4E-family genes. Data from studies in L. major and T. brucei suggest that 
functional roles can be inferred by orthology into the trypanosomatid lineage, but these 
conclusions cannot be further extrapolated to other eukaryotic organisms. 
3.1.4. Trypanosomatid IF4A 
The sequence analysis of IF4A gives a more simple interpretation than IF4E, because of a 
lower number of homologous genes in each species, and the fact that these proteins show a 
higher degree of sequence conservation. IF4A belongs to a DEAD-box helicase family, which 
includes translation factors, as well as proteins involved in splicing. The inferred 
phylogenetic relationships amongst these proteins yield two clearly separate clades (Figure 
9). In each of these clades, the phylogeny of the proteins is coincident with that of their 
organisms, strongly suggesting that a unique duplication event of an ancestor IF4A gene 
took place before the divergence of early eukaryotes. As can be seen, S. cerevisiae IF4AI 
(P10081.3) and Homo sapiens IF4A2 (Q14240.2), both having demonstrated roles in protein 
synthesis initiation are in the same clade. Consistently, the paralogous proteins IF4A-like 
FAL1 (Q12099.1) and IF4AIII (P38919.4), from S. cerevisiae and H. sapiens, respectively, have 
been shown to be involved in splicing, and consistently they belong to a separate clade. This 
analysis suggests that trypanosomatid IF4A homologous proteins of the first clade, would 
be expected to be involved in protein synthesis initiation. 
The first functional analysis of a trypanosomatid IF4A homologue was performed with a 
Leishmania infantum protein (LeIF; XP_001462692.1), initially identified as an antigen 
inducing IL12 mediated immune response in infected patients [52]. This protein shows 
RNA-dependent ATPase and ATP-dependent RNA helicase activities and interaction with 
yeast eIF4G in vitro. However, LiIF4A does not complement a yeast eIF4A deficient strain, 
leading the authors to suggest that LiIF4A is indeed the orthologue of human eIF4AIII, 
involved in splicing. The phylogenetic analysis (Figure 9) allows us to propose an 
alternative hypothesis, since LiIF4A is located in the translation factor clade. We propose 
that this protein is indeed an initiation translation factor and that its inability to complement 
yeast cells reflects the evolutionary functional divergence of trypanosomatid protein 
synthesis. This hypothesis is supported by the finding of another gene in the genome of L. 
infantum; LiIF4A-like (XP_001470194.1), which groups with the clade of splicing factors. 
Additional evidences supporting this hypothesis have been provided by knock-down of the 
two T. brucei paralogous genes, combined with metabolic labeling with radioactive amino 
acids in silenced strains. These studies showed that knock-down of TbIF4AI, but not of 
TbIF4AIII, specifically decreases the rate of protein synthesis [53]. Figure 9 shows a 
phylogenetic tree of IF4A homologous proteins from different organisms, highlighting those 
with demonstrated roles in translation (blue letters) or other functions than translation (pink 
letters). 
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Figure 9. Inferred phylogenetic relationships among putative trypanosomatid IF4A proteins and 
homologous proteins from other eukaryotes. The complete open reading frames were aligned using T-
COFEE under default parameters. LG+G was chosen as the best evolutionary model. All those proteins 
with demonstrated role in protein synthesis are located in one of these clades, whereas the second clade 
seems to group the proteins involved in splicing. ScIF4AI (P10081.3) [54] and HsIF4A2 (Q14240.2) [55] 
(blue letters), have demonstrated roles in protein synthesis, whereas ScIF4A-like FAL1 (Q12099.1) [56] 
and HsIF4AIII (P38919.4) [57] (pink letters), have been implicated in other processes. L. infantum LiIF4A 
(XP_001462692.1) (bold and underlined) has been cloned and characterized as unable to complement an 
IF4A yeast null strain [52]. 
3.1.5. Trypanosomatid IF4G 
As mentioned before, IF4G is a scaffold protein that coordinates the assembly of the 
translation initiation factors and the 40S ribosomal subunit. The middle domain of IF4G 
(MIF4G) is the hallmark of these proteins. In addition, this domain is also present in several 
other proteins not involved in translation, such as the nuclear cap-binding protein CBP80. 
This fact reflects the common origin shared by IF4G with other cap-binding proteins, being 
difficult to deduce, based only on homology, which proteins harboring this domain have 
indeed initiation factor activity. 
Five different proteins harboring MIF4G domain are present in the genome of L. major, 
named LmIF4G-1 to LmIF4G-5 [41]. All of them have clearly predictable orthologues in T. 
brucei and T. cruzi. From these, and based on different functional assays including pull-
down, yeast-two hybrid and polysome profiles, LmIF4G-3 seems to be the most probable 
orthologous with a major role in translation initiation [41, 58]. Interestingly, phylogeny 
inference shows that trypanosomatid IF4G proteins form a separate clade, implying several 
gene duplication events into the trypanosomatid lineage (Figure 10). It has been postulated 
that MIF4G domain appeared during the early stages of eukaryotic evolution [59]. 
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Interestingly, TBLASTN searches on Giardia genome database using many different MIF4G 
domains as probe, give no significant hits. This strongly suggests that this domain appeared 
during the evolution of eukaryotes, after the divergence of the Giardia lineage. This implies 
that trypanosomatids would be amongst the earliest diverging organisms harboring IF4G 
proteins. 
 
Figure 10. Inferred phylogenetic relationships among putative trypanosomatid IF4G and homologous 
proteins from other eukaryotes. Sequences are derived from Homo sapiens (Hs), Saccharomyces cerevisiae 
(Sc), L. major (Lm), T. brucei (Tb) and T. cruzi (Tc). Accession codes for GenBank or L. major database 
(http://www.genedb.org/Homepage/Lmajor) are shown in parenthesis. Sequences covering the MIF4G 
domain (PFAM cd11559) were aligned using T-COFEE under default parameters (http://tcoffee.vital-
it.ch). LG + G was chosen as the best evolutionary model using ProtTest [48]. PhyML was run using the 
algorithm Subtree Pruning and Regrafting (SPR) [49] with 5 initial starting trees. To estimate the 
robustness of the phylogenetic inference, 500 bootstrap replicates were run. LmIF4G-3, the only 
trypanosomatid IF4G-like protein that has been experimentally associated to the formation of the IF4F 
complex is indicated by an arrow. 
3.1.6. Elongation factors 
The elongation step of protein synthesis has been highly conserved trough evolution, in 
comparison with initiation. According to this, the sequences encoding for elongation factors 
can be easily inferred by homology. However, elongation factors from bacteria and eukaryotes 
are not functionally interchangeable. Moreover, the specificity of ribosomes for their 
homologous elongation factors can be changed by interchanging their stalk components [60]. 
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The eukaryotic EF-2 is a GTPase involved in translocation of the peptidyl-tRNA from the A site 
to the P site on the ribosome. Two major mechanisms involving EF-2 regulate protein 
elongation. One of them is EF-2 reversible phosphorylation [61]. The second is EF-2 inactivation 
by ADP-ribosylation of a diphthamide residue (a post-translational modification of a conserved 
histidine residue) [62, 63]. In addition, EF-2 interacts with the ribosomal P proteins that form the 
stalk region [64]. A direct interaction between the stalk base and the EF-2 has been visualized 
by cryoelectron microscopy in yeast [65]. Real time measurements, using surface plasmon 
resonance (SPR), demonstrated the binding of rat EF-2 to rat P1 and P2 proteins, with a higher 
affinity for P1 (KD 3.810-8 M) than for P2 (KD 2.210-6 M) [66]. Moreover, antibodies against the 
conserved C-terminal region of ribosomal P proteins inhibited the elongation step of protein 
synthesis, blocking the binding of EF-2 to the ribosome as well as its ribosome dependent 
GTPase activity [67]. Below, we will summarize evidence of structural and functional 
divergences amongst eukaryotes at the ribosomal stalk level, and its partner EF-2.  
It has been largely demonstrated that the antifungal sordarin, which selectively inhibits some 
eukaryotic ribosomes, acts at the elongation step. Detailed studies about its action mechanisms 
have revealed that specificity of this compound for a group of fungi is due to specific 
molecular features of their stalk components (mainly the P0 protein) and EF-2 [68, 69]. 
On the other hand, trypanosomatid ribosomes have been shown to be highly resistant, in 
comparison to mammalian particles, to two ribosome inactivating proteins; ricin and 
trichosanthin [70, 71]. These toxins bind initially to the ribosomal stalk and depurinate a 
conserved base on the 28S rRNA, blocking the binding of EF-2 to ribosomes, supporting the 
idea that the trypanosomatid stalk has specific features. 
 
Figure 11. Model of T. cruzi EF-2. 
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The amino acid sequence of TcEF-2 was identified by probing the T. cruzi Gene Data Base 
(http://www.genedb.org) with the amino acid sequence of S. cerevisiae EF-2. Two identical 
copies of the TcEF-2 gene were found. The TcEF-2 protein was 60% identical to ScEF-2, and 
both EF-2 shared over 76% homology. In contrast to ScEF-2 that is regulated by 
phosphorylation of Threonine 57, TcEF-2 presented a Methionine in this position, 
suggesting a lack of regulation through phosphorylation (Figure 11). The histidine involved 
in ADP-ribosylation in ScEF-2 (H699) is conserved in trypanosomatids (H703 in T. cruzi), 
and consequently, diphtheria toxin inactivates protein synthesis in T. brucei [70]. Secondary 
structure comparative analysis showed an overall conserved architecture. The four 
canonical helices of domain I (GTPase) were conserved as well as the motif involved in 
nucleotide binding [72]. Using PHYRE protein fold recognition server [73], we generated a 
3D model of TcEF-2 that contains the six structural domains described for ScEF-2 [74]. 
Therefore, taking into account the high structural similarity between ScEF-2 and TcEF-2, it 
may be assumed that the different domains have conserved similar functions. The 
interaction of TcEF-2 with the ribosomal P proteins showed that all P1/P2 proteins interacted 
with TcEF-2 with similar affinities. Interestingly, TcP0 showed a decreased affinity in 
concordance with its modified C-terminal region. Our results are in agreement with those 
reported by Bargis-Surgey et al. [67] for the rat homologues. However, in T. cruzi no 
differential interaction between the EF-2 and the different P1/P2 proteins was observed. 
Unfortunately, data from functional comparison between trypanosomatid EF-2 and its 
orthologous in model species, such as yeast functional complementation, are not yet available. 
3.2. Selective inhibition of trypanosomatid ribosomes by paromomycin 
Aminoglycosides are a group of antibiotics binding to the decoding center of rRNA. As a 
result, aminoglycosides interfere with protein synthesis, facilitating amino acid 
misincorporation. The target site of aminoglycosides is the helix 44 of the 18S rRNA. As noted 
before, this helix is located in the ES12, the only expansion segment which is shorter in T. 
cruzi than in other eukaryotes, being intermediate between bacterial and higher eukaryotes 
[1]. Paromomycin is an aminoglycoside antibiotic with low toxicity to mammalian cells. This 
antibiotic has shown strong anti-leishmania activity when used alone or in combination with 
other drugs [75]. In a recent work, advances on the molecular basis for the differential effect 
of paromomycin on Leishmania have been reported [4]. In this work it was demonstrated that 
paromomycin selectively inhibits the rate of in vitro protein synthesis by trypanosomatid 
ribosomes, comparing to mammalian extracts. Moreover, the effect of paromomycin was 
even more dramatic when translation misreading was evaluated. Finally, affinity 
measurements using BIACORE demonstrated that paromomycin displays high affinity for 
the RNA oligonucleotide corresponding to the decoding site of trypanosomatids, whereas no 
interaction was detected with the oligonucleotide corresponding to the mammalian site. 
4. Conclusion 
In summary, we have described several direct and indirect evidences justifying future in-
deep studies on the trypanosomatid protein synthesis machinery.  
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The sequence and functional analysis of trypanosomatid homologous to well-characterized 
initiation factors, along with the fact that SL sequence is present in all the trypanosomatid 
mRNAs, strongly suggest that protein synthesis initiation would have remarkable unique 
features in these protozoa. This hypothesis is reinforced by structural features of T. cruzi 
ribosomes, where a large, trypanosomatid-specific rRNA extra density is present adjacent to 
the platform region, involved in translation initiation. 
The sequence analysis of ribosomal proteins also shows peculiarities in T. cruzi, being L19 
and S21 proteins the most notable examples, possessing large trypanosomatid-specific 
domains with unknown functional roles. 
Even when the elongation step of translation is much more conserved through evolution, 
the stalk composition and structure also seem to have special features in trypanosomatids. 
Consistently with this observation, some ribotoxins binding to this site show differential 
selectivity against parasite ribosomes. Unfortunately, no functional data are available on the 
functional similarities between trypanosomatid and mammalian elongation factors. 
Paromomycin is the first example of a compound with a well characterized action 
mechanism, showing higher activity on trypanosomatid translation machinery in 
comparison with its mammalian counterpart. This fact, along with the number of key 
features of trypanosomatid ribosomes and translation factors, should strongly encourage the 
future search for novel, trypanosomatid-specific translation inhibitors. 
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